BG60348B2 - Nаnв диагностика: полинуклеотиди, приложими за скрининг на вируса на хепатит с - Google Patents

Nаnв диагностика: полинуклеотиди, приложими за скрининг на вируса на хепатит с Download PDF

Info

Publication number
BG60348B2
BG60348B2 BG095495A BG9549591A BG60348B2 BG 60348 B2 BG60348 B2 BG 60348B2 BG 095495 A BG095495 A BG 095495A BG 9549591 A BG9549591 A BG 9549591A BG 60348 B2 BG60348 B2 BG 60348B2
Authority
BG
Bulgaria
Prior art keywords
sequence
hcv
oligomer
sequences
polynucleotide
Prior art date
Application number
BG095495A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Jang Han
Michael Urdea
Amy Weiner
Original Assignee
Novartis Vaccines & Diagnostics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostics, Inc. filed Critical Novartis Vaccines & Diagnostics, Inc.
Publication of BG60348B2 publication Critical patent/BG60348B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG095495A 1989-05-18 1991-11-18 Nаnв диагностика: полинуклеотиди, приложими за скрининг на вируса на хепатит с BG60348B2 (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35596189A 1989-05-18 1989-05-18
US45663789A 1989-12-21 1989-12-21
US50543590A 1990-04-04 1990-04-04
PCT/US1990/002853 WO1990014436A1 (en) 1989-05-18 1990-05-18 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus

Publications (1)

Publication Number Publication Date
BG60348B2 true BG60348B2 (bg) 1994-09-30

Family

ID=27408242

Family Applications (1)

Application Number Title Priority Date Filing Date
BG095495A BG60348B2 (bg) 1989-05-18 1991-11-18 Nаnв диагностика: полинуклеотиди, приложими за скрининг на вируса на хепатит с

Country Status (17)

Country Link
EP (1) EP0398748B1 (de)
JP (3) JP2656996B2 (de)
AT (1) ATE211772T1 (de)
AU (1) AU638719B2 (de)
BG (1) BG60348B2 (de)
CA (1) CA2017157C (de)
DE (1) DE69033891T2 (de)
DK (1) DK0398748T3 (de)
ES (1) ES2166749T3 (de)
FI (1) FI105279B (de)
GE (1) GEP20002164B (de)
HU (1) HUT59964A (de)
LV (1) LV10729B (de)
MC (1) MC2188A1 (de)
NO (1) NO303503B1 (de)
RO (1) RO113059B1 (de)
WO (1) WO1990014436A1 (de)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6489246A (en) * 1987-09-30 1989-04-03 Sony Corp Fixing method for color sorting mechanism of color cathode-ray tube
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
BR9006422A (pt) * 1989-12-18 1991-09-24 Wellcome Found Processo para preparar um polipeptidio viral pt-nanbh e processo para detectar o mesmo
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
JP3268502B2 (ja) 1990-06-12 2002-03-25 徹雄 中村 非ａ非ｂ型肝炎ウイルス関連ポリヌクレオチド、ポリペプ タイド
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
DE69106141T2 (de) * 1990-06-30 1995-05-24 Akzo Nobel Nv Non-a non-b sequenzen.
EP0469348B1 (de) * 1990-07-11 1997-03-12 SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. cDNS-Sequenz und Detektion des Hepatitis C-Virus
WO1992001714A1 (fr) * 1990-07-24 1992-02-06 Yamanouchi Pharmaceutical Co., Ltd. Antigene du virus de l'hepatite non a, non b
WO1992002642A1 (en) * 1990-08-10 1992-02-20 Chiron Corporation Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
AU1459792A (en) * 1991-01-14 1992-08-27 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
IE65424B1 (en) * 1991-03-01 1995-10-18 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-A non-B virus
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0510952A1 (de) * 1991-04-26 1992-10-28 Immuno Japan Inc. Oligonukleotid-Primer und ihre Anwendung zum Nachweis von Non-A, Non-B-Hepatitis mit höchster Genauigkeit
FR2677372B1 (fr) * 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
IT1249684B (it) * 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
ATE241704T1 (de) * 1991-08-27 2003-06-15 Hoffmann La Roche Primers und sondern zum nachweis von hepatitis c
WO1993005181A1 (en) * 1991-09-12 1993-03-18 Cedars-Sinai Medical Center Direct detection of hepatitis c virus rna
HU227510B1 (en) * 1991-09-13 2011-07-28 Novartis Vaccines & Diagnostic Immunoreactive hepatitis c virus polypeptide compositions
CA2099883A1 (en) * 1991-11-07 1993-05-08 John A. Kink Epitope mapping of the c33c region of hcv
ES2065863T3 (es) * 1991-11-21 2003-09-01 Common Services Agency Analisis para la deteccion de virus de la hepatitis c.
GB9204274D0 (en) * 1992-02-28 1992-04-08 Wellcome Found Novel peptides
US5866139A (en) * 1992-06-04 1999-02-02 Institut Pasteur Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
US5922857A (en) * 1992-09-28 1999-07-13 Chiron Corporation Methods and compositions for controlling translation of HCV proteins
JPH06153961A (ja) * 1992-11-27 1994-06-03 Imuno Japan:Kk Ｃ型肝炎ウイルス部分遺伝子、ならびにｃ型肝炎ウイルス遺 伝子の高感度検出法
JPH08510240A (ja) 1993-05-12 1996-10-29 カイロン コーポレイション Ｃ型肝炎ウイルスｅ２／ｎｓ１領域の保存モチーフ
AU3241095A (en) * 1994-07-29 1996-03-04 Chiron Corporation Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
EP1510580B1 (de) 1994-07-29 2008-12-10 Novartis Vaccines and Diagnostics, Inc. Hepatitis C E2 verkuerzte Polypeptid sowie Verfahen zu seiner Herstellung
US5837442A (en) 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
ATE437951T1 (de) 1997-05-06 2009-08-15 Novartis Vaccines & Diagnostic Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
DE19832050C2 (de) * 1998-07-16 2002-10-10 Biotest Pharma Gmbh Verfahren zum Nachweis von Hepatitis B- bzw. Hepatitis C-Virusgenomen in Plasmaproben und spezifische Primer
CA2366688A1 (en) 1999-02-26 2000-08-31 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
EP1156781B1 (de) 1999-02-26 2005-06-08 Chiron Corporation Mikroemulsionen mit adsorbierten makromolekülen und mikropartikeln
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US6630298B2 (en) * 2000-06-15 2003-10-07 Chiron Corporation HCV antigen/antibody combination assay
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
DE60130998T2 (de) 2000-08-17 2008-07-17 Tripep Ab Ribavirin-enthaltende vakzine
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
ES2624854T3 (es) 2001-05-31 2017-07-17 Glaxosmithkline Biologicals Sa Partículas de replicón de alfavirus quimérico
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
EP1531796B1 (de) 2002-02-20 2016-09-28 GlaxoSmithKline Biologicals SA Mikropartikel mit adsorbierten polypeptidhaltigen molekülen
US7598421B2 (en) 2002-05-08 2009-10-06 Ucl Biomedica Plc Materials for the delivery of biologically-active material to cells
CA2511512C (en) 2002-12-27 2013-10-29 Chiron Corporation Immunogenic compositions containing phospholipid
WO2004084936A2 (en) 2003-02-06 2004-10-07 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
MXPA05008342A (es) 2003-02-06 2006-02-28 Cerus Corp Listeria atenuada para la entrada a las celulas no fagociticas, vacunas que comprenden la listeria, y metodos de uso de las mismas.
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
WO2006078318A2 (en) 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
ATE527545T1 (de) 2004-08-27 2011-10-15 Novartis Vaccines & Diagnostic Hcv-antigene zur mehrfachen epitopfusion mit modifizierten proteolytischen spaltungsorten und verwendungen davon
CA2618429A1 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
WO2008046923A2 (en) * 2006-10-20 2008-04-24 Innogenetics N.V. Methodology for analysis of sequence variations within the hcv ns3/4a genomic region
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
EP3067048B1 (de) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Zusammensetzungen zur induzierung von immunreaktionen
WO2009130588A2 (en) 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
KR20110027695A (ko) 2008-05-19 2011-03-16 아두로 바이오테크 Ｐｒｆａ＊ 돌연변이 리스테리아를 포함하는 조성물 및 그것의 사용방법
US20120100171A1 (en) 2009-03-09 2012-04-26 William Henry Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
FI122954B (fi) 2011-01-31 2012-09-14 Teknoware Oy LED-putkilamppu ja valaisinjärjestely

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
CN1074422C (zh) * 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JP2656995B2 (ja) * 1989-03-17 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
CA2079677A1 (en) * 1990-04-03 1991-10-04 Kenneth H. Burk Purified hcv and hcv proteins and peptides

Also Published As

Publication number Publication date
JPH1089A (ja) 1998-01-06
EP0398748A3 (de) 1991-10-23
CA2017157C (en) 2003-07-29
JP3698520B2 (ja) 2005-09-21
RO113059B1 (ro) 1998-03-30
JPH10113176A (ja) 1998-05-06
EP0398748B1 (de) 2002-01-09
HUT59964A (en) 1992-07-28
NO914517D0 (no) 1991-11-18
DK0398748T3 (da) 2002-03-18
FI915443A0 (fi) 1991-11-18
JP2656996B2 (ja) 1997-09-24
DE69033891D1 (de) 2002-02-21
FI105279B (fi) 2000-07-14
CA2017157A1 (en) 1990-11-18
ES2166749T3 (es) 2002-05-01
MC2188A1 (fr) 1992-09-16
NO303503B1 (no) 1998-07-20
AU5812390A (en) 1990-12-18
NO914517L (no) 1992-01-16
EP0398748A2 (de) 1990-11-22
LV10729A (lv) 1995-06-20
JP3701754B2 (ja) 2005-10-05
WO1990014436A1 (en) 1990-11-29
AU638719B2 (en) 1993-07-08
DE69033891T2 (de) 2002-08-29
HU904754D0 (en) 1992-01-28
GEP20002164B (en) 2000-07-10
ATE211772T1 (de) 2002-01-15
JPH05500155A (ja) 1993-01-21
LV10729B (en) 1995-12-20

Similar Documents

Publication Publication Date Title
BG60348B2 (bg) Nаnв диагностика: полинуклеотиди, приложими за скрининг на вируса на хепатит с
US5714596A (en) NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5863719A (en) Methods for detecting hepatitis C virus using polynucleotides specific for same
JP4251407B2 (ja) Ｈｃｖ単離物のタイピング法
JP2714255B2 (ja) Ｎａｎｂｖ診断法：ｃ型肝炎ウイルスのスクリーニングに有用なポリヌクレオチド
Frangeul et al. Mutations in NS5A region of hepatitis C virus genome correlate with presence of NS5A antibodies and response to interferon therapy for most common European hepatitis C virus genotypes
AU2003218111B8 (en) Methods and compositions for identifying and characterizing hepatitis C
RU2145635C1 (ru) Олигомер (варианты), способ обнаружения последовательности hcv (варианты), набор для обнаружения, способ получения крови
JP2000508907A (ja) Ｈｃｖを遺伝子型分類するためのヘテロ二本鎖トラッキングアッセイ（ｈｔａ）
PT94081B (pt) Diagnosticos para o nambv: polinucleotidos uteis na deteccao do virus da hepatite c
KR20070037228A (ko) Ｈｃｖ 특이 유전자 검출키트